Perspective Therapeutics (CATX) Construction in Progress (2011)
Perspective Therapeutics' (CATX) quarterly Construction in Progress came in at $123613.0 in Q2 2011.
Perspective Therapeutics (CATX) Construction in Progress (2011) Analysis & Trends
Perspective Therapeutics has disclosed Construction in Progress across 1 years of filings, most recently posting $123613.0 for Q2 2011.
- Construction in Progress for Q2 2011 came in at $123613.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2011 was $123613.0 (changed N/A YoY), and the FY2011 annual result was $123613.0, changed N/A from the prior year.
- Construction in Progress came in at $123613.0 for Q2 2011 at Perspective Therapeutics.
- In the past five years, Construction in Progress ranged from a high of $123613.0 in Q2 2011 to a low of $123613.0 in Q2 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.12 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 509.50 Mn |
| 10 | Perspective Therapeutics | 308.74 Mn | 308.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2011 | 123,613.00 |